EFFICACY AND SAFETY OF PROPAFENONE IN CONGENITAL JUNCTIONAL ECTOPIC TACHYCARDIA

被引:45
作者
PAUL, T [1 ]
REIMER, A [1 ]
JANOUSEK, J [1 ]
KALLFELZ, HC [1 ]
机构
[1] UNIV HOSP MOTOL, CTR PEDIAT CARDIOL & CARDIAC SURG, PRAGUE, CZECHOSLOVAKIA
关键词
D O I
10.1016/0735-1097(92)90192-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Class IC antiarrhythmic drugs have recently been shown to be effective in some patients with atrial ectopic tachycardia. We therefore studied the efficacy of these drugs in patients with congenital junctional ectopic tachycardia. Background. Follow-up data on patients with junctional ectopic tachycardia suggest that this potentially lethal arrhythmia may cease spontaneously in a significant proportion of affected children. Therefore, temporary antiarrhythmic treatment appears to be the therapy of choice. Methods. The efficacy of propafenone was prospectively assessed in four infants with junctional ectopic tachycardia (ventricular rate 180, 185, 210 and 320 beats/min, respectively). The diagnosis of junctional ectopic tachycardia was established before the age of 2 months in all four infants. Propafenone was given orally in a mean dose of 350 (300 to 500) mg/m2 body surface area per day. Success of therapy was determined by serial electrocardiograms (ECGs) and Holter ambulatory ECG monitoring. Results. In two patients, junctional ectopic tachycardia was completely suppressed. In the remaining two patients, the tachycardia rate decreased to <150 beats/min. Serum propafenone levels did not correlate with efficacy of treatment. The mean duration of therapy was 18 months (range 3 to 36). No chemical or clinical side effects were noted. Conclusions. Because of its effectiveness, safety and lack of side effects, propafenone appears to be a valuable drug in the treatment of junctional ectopic tachycardia in newborns and infants.
引用
收藏
页码:911 / 914
页数:4
相关论文
共 26 条
[1]  
[Anonymous], 1989, NEW ENGL J MED, V321, P406
[2]  
BATISSE A, 1979, ARCH FR PEDIATR, V36, P551
[3]   DESUBITANEIS-MORTIBUS .16. INTRACTABLE TACHYCARDIA IN INFANCY [J].
BRECHENMACHER, C ;
COUMEL, P ;
JAMES, TN .
CIRCULATION, 1976, 53 (02) :377-381
[4]  
DRESSLER F, 1985, MONATSSCHR KINDERH, V133, P154
[5]   PROARRHYTHMIA, CARDIAC-ARREST AND DEATH IN YOUNG-PATIENTS RECEIVING ENCAINIDE AND FLECAINIDE [J].
FISH, FA ;
GILLETTE, PC ;
BENSON, DW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (02) :356-365
[6]   SUPRAVENTRICULAR TACHYCARDIA IN CHILDREN - CLINICAL-FEATURES, RESPONSE TO TREATMENT, AND LONG-TERM FOLLOW-UP IN 217 PATIENTS [J].
GARSON, A ;
GILLETTE, PC ;
MCNAMARA, DG .
JOURNAL OF PEDIATRICS, 1981, 98 (06) :875-882
[7]   ELECTROPHYSIOLOGIC STUDIES OF SUPRAVENTRICULAR TACHYCARDIA IN CHILDREN .1. CLINICAL-ELECTROPHYSIOLOGIC CORRELATIONS [J].
GARSON, A ;
GILLETTE, PC .
AMERICAN HEART JOURNAL, 1981, 102 (02) :233-250
[8]   JUNCTIONAL ECTOPIC TACHYCARDIA IN CHILDREN - ELECTROCARDIOGRAPHY, ELECTROPHYSIOLOGY AND PHARMACOLOGIC RESPONSE [J].
GARSON, A ;
GILLETTE, PC .
AMERICAN JOURNAL OF CARDIOLOGY, 1979, 44 (02) :298-302
[9]   USEFULNESS OF INTRAVENOUS PROPAFENONE FOR CONTROL OF POSTOPERATIVE JUNCTIONAL ECTOPIC TACHYCARDIA [J].
GARSON, A ;
MOAK, JP ;
SMITH, RT ;
NORTON, JB .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (15) :1422-1424
[10]   JUNCTIONAL AUTOMATIC ECTOPIC TACHYCARDIA - NEW PROPOSED TREATMENT BY TRANSCATHETER HIS-BUNDLE ABLATION [J].
GILLETTE, PC ;
GARSON, A ;
PORTER, CJ ;
OTT, D ;
MCVEY, P ;
ZINNER, A ;
BLAIR, H .
AMERICAN HEART JOURNAL, 1983, 106 (04) :619-623